Article info
PDFOriginal article
The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment
- Correspondence to Dr Simon John Whitehead, Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands WV10 0QP, UK; simonwhitehead{at}nhs.net
Citation
The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment
Publication history
- Received December 16, 2013
- Revised February 3, 2014
- Accepted February 12, 2014
- First published April 7, 2014.
Online issue publication
February 27, 2018
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions